Global Orphan Drugs Market Insight and Forecast to 2026
The research team projects that the Orphan Drugs market size will grow from XXX in 2019 to XXX by 2026, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to 2026.
The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 30 major countries. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth. The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.
By Market Players:
Novartis AG
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
Bristol-Myers Squibb Company
Alexion Pharmaceuticals, Inc.
Celgene Corporation
AstraZeneca
Sanofi S.A.
Pfizer, Inc.
Novo Nordisk A/S
Merck & Co., Inc.
Takeda
Eisai Co., Ltd.
Johnson & Johnson
GlaxoSmithKline
Daiichi Sankyo Company Limited
Amgen, Inc.
Biogen, Inc.
Bayer AG
By Type
Oncology
Gastrointestinal
Pulmonary
Neurology
Hematology
Cardio-vascular
Metabolic disorders
Endocrinology
Infectious diseases
By Application
Hospital Pharmacies
Speciality Pharmacies
Retail pharmacies
Others
By Regions/Countries:
North America
United States
Canada
Mexico
East Asia
China
Japan
South Korea
Europe
Germany
United Kingdom
France
Italy
South Asia
India
Southeast Asia
Indonesia
Thailand
Singapore
Middle East
Turkey
Saudi Arabia
Iran
Africa
Nigeria
South Africa
Oceania
Australia
South America
Points Covered in The Report
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
The report focuses on Global, Top 10 Regions and Top 50 Countries Market Size of Orphan Drugs 2015-2020, and development forecast 2021-2026 including industries, major players/suppliers worldwide and market share by regions, with company and product introduction, position in the market including their market status and development trend by types and applications which will provide its price and profit status, and marketing status & market growth drivers and challenges, with base year as 2019.
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2015-2020 & Sales by Product Types.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2021-2026. Further the report provides break down details about each region & countries covered in the report. Identifying its production, consumption, import & export, sales volume & revenue forecast.
Market Analysis by Product Type: The report covers majority Product Types in the Orphan Drugs Industry, including its product specifications by each key player, volume, sales by Volume and Value (M USD).
Market Analysis by Application Type: Based on the Orphan Drugs Industry and its applications, the market is further sub-segmented into several major Application of its industry. It provides you with the market size, CAGR & forecast by each industry applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report will provide with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
COVID-19 Impact
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Orphan Drugs market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 30 major countries. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth. The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.
By Market Players:
Novartis AG
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
Bristol-Myers Squibb Company
Alexion Pharmaceuticals, Inc.
Celgene Corporation
AstraZeneca
Sanofi S.A.
Pfizer, Inc.
Novo Nordisk A/S
Merck & Co., Inc.
Takeda
Eisai Co., Ltd.
Johnson & Johnson
GlaxoSmithKline
Daiichi Sankyo Company Limited
Amgen, Inc.
Biogen, Inc.
Bayer AG
By Type
Oncology
Gastrointestinal
Pulmonary
Neurology
Hematology
Cardio-vascular
Metabolic disorders
Endocrinology
Infectious diseases
By Application
Hospital Pharmacies
Speciality Pharmacies
Retail pharmacies
Others
By Regions/Countries:
North America
United States
Canada
Mexico
East Asia
China
Japan
South Korea
Europe
Germany
United Kingdom
France
Italy
South Asia
India
Southeast Asia
Indonesia
Thailand
Singapore
Middle East
Turkey
Saudi Arabia
Iran
Africa
Nigeria
South Africa
Oceania
Australia
South America
Points Covered in The Report
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
The report focuses on Global, Top 10 Regions and Top 50 Countries Market Size of Orphan Drugs 2015-2020, and development forecast 2021-2026 including industries, major players/suppliers worldwide and market share by regions, with company and product introduction, position in the market including their market status and development trend by types and applications which will provide its price and profit status, and marketing status & market growth drivers and challenges, with base year as 2019.
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2015-2020 & Sales by Product Types.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2021-2026. Further the report provides break down details about each region & countries covered in the report. Identifying its production, consumption, import & export, sales volume & revenue forecast.
Market Analysis by Product Type: The report covers majority Product Types in the Orphan Drugs Industry, including its product specifications by each key player, volume, sales by Volume and Value (M USD).
Market Analysis by Application Type: Based on the Orphan Drugs Industry and its applications, the market is further sub-segmented into several major Application of its industry. It provides you with the market size, CAGR & forecast by each industry applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report will provide with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
COVID-19 Impact
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Orphan Drugs market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Orphan Drugs Revenue
1.4 Market Analysis by Type
1.4.1 Global Orphan Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Oncology
1.4.3 Gastrointestinal
1.4.4 Pulmonary
1.4.5 Neurology
1.4.6 Hematology
1.4.7 Cardio-vascular
1.4.8 Metabolic disorders
1.4.9 Endocrinology
1.4.10 Infectious diseases
1.5 Market by Application
1.5.1 Global Orphan Drugs Market Share by Application: 2021-2026
1.5.2 Hospital Pharmacies
1.5.3 Speciality Pharmacies
1.5.4 Retail pharmacies
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Orphan Drugs Market Perspective (2021-2026)
2.2 Orphan Drugs Growth Trends by Regions
2.2.1 Orphan Drugs Market Size by Regions: 2015 VS 2021 VS 2026
2.2.2 Orphan Drugs Historic Market Size by Regions (2015-2020)
2.2.3 Orphan Drugs Forecasted Market Size by Regions (2021-2026)
3 MARKET COMPETITION BY MANUFACTURERS
3.1 Global Orphan Drugs Production Capacity Market Share by Manufacturers (2015-2020)
3.2 Global Orphan Drugs Revenue Market Share by Manufacturers (2015-2020)
3.3 Global Orphan Drugs Average Price by Manufacturers (2015-2020)
4 ORPHAN DRUGS PRODUCTION BY REGIONS
4.1 North America
4.1.1 North America Orphan Drugs Market Size (2015-2026)
4.1.2 Orphan Drugs Key Players in North America (2015-2020)
4.1.3 North America Orphan Drugs Market Size by Type (2015-2020)
4.1.4 North America Orphan Drugs Market Size by Application (2015-2020)
4.2 East Asia
4.2.1 East Asia Orphan Drugs Market Size (2015-2026)
4.2.2 Orphan Drugs Key Players in East Asia (2015-2020)
4.2.3 East Asia Orphan Drugs Market Size by Type (2015-2020)
4.2.4 East Asia Orphan Drugs Market Size by Application (2015-2020)
4.3 Europe
4.3.1 Europe Orphan Drugs Market Size (2015-2026)
4.3.2 Orphan Drugs Key Players in Europe (2015-2020)
4.3.3 Europe Orphan Drugs Market Size by Type (2015-2020)
4.3.4 Europe Orphan Drugs Market Size by Application (2015-2020)
4.4 South Asia
4.4.1 South Asia Orphan Drugs Market Size (2015-2026)
4.4.2 Orphan Drugs Key Players in South Asia (2015-2020)
4.4.3 South Asia Orphan Drugs Market Size by Type (2015-2020)
4.4.4 South Asia Orphan Drugs Market Size by Application (2015-2020)
4.5 Southeast Asia
4.5.1 Southeast Asia Orphan Drugs Market Size (2015-2026)
4.5.2 Orphan Drugs Key Players in Southeast Asia (2015-2020)
4.5.3 Southeast Asia Orphan Drugs Market Size by Type (2015-2020)
4.5.4 Southeast Asia Orphan Drugs Market Size by Application (2015-2020)
4.6 Middle East
4.6.1 Middle East Orphan Drugs Market Size (2015-2026)
4.6.2 Orphan Drugs Key Players in Middle East (2015-2020)
4.6.3 Middle East Orphan Drugs Market Size by Type (2015-2020)
4.6.4 Middle East Orphan Drugs Market Size by Application (2015-2020)
4.7 Africa
4.7.1 Africa Orphan Drugs Market Size (2015-2026)
4.7.2 Orphan Drugs Key Players in Africa (2015-2020)
4.7.3 Africa Orphan Drugs Market Size by Type (2015-2020)
4.7.4 Africa Orphan Drugs Market Size by Application (2015-2020)
4.8 Oceania
4.8.1 Oceania Orphan Drugs Market Size (2015-2026)
4.8.2 Orphan Drugs Key Players in Oceania (2015-2020)
4.8.3 Oceania Orphan Drugs Market Size by Type (2015-2020)
4.8.4 Oceania Orphan Drugs Market Size by Application (2015-2020)
4.9 South America
4.9.1 South America Orphan Drugs Market Size (2015-2026)
4.9.2 Orphan Drugs Key Players in South America (2015-2020)
4.9.3 South America Orphan Drugs Market Size by Type (2015-2020)
4.9.4 South America Orphan Drugs Market Size by Application (2015-2020)
4.10 Rest of the World
4.10.1 Rest of the World Orphan Drugs Market Size (2015-2026)
4.10.2 Orphan Drugs Key Players in Rest of the World (2015-2020)
4.10.3 Rest of the World Orphan Drugs Market Size by Type (2015-2020)
4.10.4 Rest of the World Orphan Drugs Market Size by Application (2015-2020)
5 ORPHAN DRUGS CONSUMPTION BY REGION
5.1 North America
5.1.1 North America Orphan Drugs Consumption by Countries
5.1.2 United States
5.1.3 Canada
5.1.4 Mexico
5.2 East Asia
5.2.1 East Asia Orphan Drugs Consumption by Countries
5.2.2 China
5.2.3 Japan
5.2.4 South Korea
5.3 Europe
5.3.1 Europe Orphan Drugs Consumption by Countries
5.3.2 Germany
5.3.3 United Kingdom
5.3.4 France
5.3.5 Italy
5.3.6 Russia
5.3.7 Spain
5.3.8 Netherlands
5.3.9 Switzerland
5.3.10 Poland
5.4 South Asia
5.4.1 South Asia Orphan Drugs Consumption by Countries
5.4.2 India
5.4.3 Pakistan
5.4.4 Bangladesh
5.5 Southeast Asia
5.5.1 Southeast Asia Orphan Drugs Consumption by Countries
5.5.2 Indonesia
5.5.3 Thailand
5.5.4 Singapore
5.5.5 Malaysia
5.5.6 Philippines
5.5.7 Vietnam
5.5.8 Myanmar
5.6 Middle East
5.6.1 Middle East Orphan Drugs Consumption by Countries
5.6.2 Turkey
5.6.3 Saudi Arabia
5.6.4 Iran
5.6.5 United Arab Emirates
5.6.6 Israel
5.6.7 Iraq
5.6.8 Qatar
5.6.9 Kuwait
5.6.10 Oman
5.7 Africa
5.7.1 Africa Orphan Drugs Consumption by Countries
5.7.2 Nigeria
5.7.3 South Africa
5.7.4 Egypt
5.7.5 Algeria
5.7.6 Morocco
5.8 Oceania
5.8.1 Oceania Orphan Drugs Consumption by Countries
5.8.2 Australia
5.8.3 New Zealand
5.9 South America
5.9.1 South America Orphan Drugs Consumption by Countries
5.9.2 Brazil
5.9.3 Argentina
5.9.4 Columbia
5.9.5 Chile
5.9.6 Venezuela
5.9.7 Peru
5.9.8 Puerto Rico
5.9.9 Ecuador
5.10 Rest of the World
5.10.1 Rest of the World Orphan Drugs Consumption by Countries
5.10.2 Kazakhstan
6 ORPHAN DRUGS SALES MARKET BY TYPE (2015-2026)
6.1 Global Orphan Drugs Historic Market Size by Type (2015-2020)
6.2 Global Orphan Drugs Forecasted Market Size by Type (2021-2026)
7 ORPHAN DRUGS CONSUMPTION MARKET BY APPLICATION(2015-2026)
7.1 Global Orphan Drugs Historic Market Size by Application (2015-2020)
7.2 Global Orphan Drugs Forecasted Market Size by Application (2021-2026)
8 COMPANY PROFILES AND KEY FIGURES IN ORPHAN DRUGS BUSINESS
8.1 Novartis AG
8.1.1 Novartis AG Company Profile
8.1.2 Novartis AG Orphan Drugs Product Specification
8.1.3 Novartis AG Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.2 Eli Lilly and Company
8.2.1 Eli Lilly and Company Company Profile
8.2.2 Eli Lilly and Company Orphan Drugs Product Specification
8.2.3 Eli Lilly and Company Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.3 F. Hoffmann-La Roche Ltd.
8.3.1 F. Hoffmann-La Roche Ltd. Company Profile
8.3.2 F. Hoffmann-La Roche Ltd. Orphan Drugs Product Specification
8.3.3 F. Hoffmann-La Roche Ltd. Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.4 Bristol-Myers Squibb Company
8.4.1 Bristol-Myers Squibb Company Company Profile
8.4.2 Bristol-Myers Squibb Company Orphan Drugs Product Specification
8.4.3 Bristol-Myers Squibb Company Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.5 Alexion Pharmaceuticals, Inc.
8.5.1 Alexion Pharmaceuticals, Inc. Company Profile
8.5.2 Alexion Pharmaceuticals, Inc. Orphan Drugs Product Specification
8.5.3 Alexion Pharmaceuticals, Inc. Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.6 Celgene Corporation
8.6.1 Celgene Corporation Company Profile
8.6.2 Celgene Corporation Orphan Drugs Product Specification
8.6.3 Celgene Corporation Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.7 AstraZeneca
8.7.1 AstraZeneca Company Profile
8.7.2 AstraZeneca Orphan Drugs Product Specification
8.7.3 AstraZeneca Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.8 Sanofi S.A.
8.8.1 Sanofi S.A. Company Profile
8.8.2 Sanofi S.A. Orphan Drugs Product Specification
8.8.3 Sanofi S.A. Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.9 Pfizer, Inc.
8.9.1 Pfizer, Inc. Company Profile
8.9.2 Pfizer, Inc. Orphan Drugs Product Specification
8.9.3 Pfizer, Inc. Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.10 Novo Nordisk A/S
8.10.1 Novo Nordisk A/S Company Profile
8.10.2 Novo Nordisk A/S Orphan Drugs Product Specification
8.10.3 Novo Nordisk A/S Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.11 Merck & Co., Inc.
8.11.1 Merck & Co., Inc. Company Profile
8.11.2 Merck & Co., Inc. Orphan Drugs Product Specification
8.11.3 Merck & Co., Inc. Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.12 Takeda
8.12.1 Takeda Company Profile
8.12.2 Takeda Orphan Drugs Product Specification
8.12.3 Takeda Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.13 Eisai Co., Ltd.
8.13.1 Eisai Co., Ltd. Company Profile
8.13.2 Eisai Co., Ltd. Orphan Drugs Product Specification
8.13.3 Eisai Co., Ltd. Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.14 Johnson & Johnson
8.14.1 Johnson & Johnson Company Profile
8.14.2 Johnson & Johnson Orphan Drugs Product Specification
8.14.3 Johnson & Johnson Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.15 GlaxoSmithKline
8.15.1 GlaxoSmithKline Company Profile
8.15.2 GlaxoSmithKline Orphan Drugs Product Specification
8.15.3 GlaxoSmithKline Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.16 Daiichi Sankyo Company Limited
8.16.1 Daiichi Sankyo Company Limited Company Profile
8.16.2 Daiichi Sankyo Company Limited Orphan Drugs Product Specification
8.16.3 Daiichi Sankyo Company Limited Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.17 Amgen, Inc.
8.17.1 Amgen, Inc. Company Profile
8.17.2 Amgen, Inc. Orphan Drugs Product Specification
8.17.3 Amgen, Inc. Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.18 Biogen, Inc.
8.18.1 Biogen, Inc. Company Profile
8.18.2 Biogen, Inc. Orphan Drugs Product Specification
8.18.3 Biogen, Inc. Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.19 Bayer AG
8.19.1 Bayer AG Company Profile
8.19.2 Bayer AG Orphan Drugs Product Specification
8.19.3 Bayer AG Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
9 PRODUCTION AND SUPPLY FORECAST
9.1 Global Forecasted Production of Orphan Drugs (2021-2026)
9.2 Global Forecasted Revenue of Orphan Drugs (2021-2026)
9.3 Global Forecasted Price of Orphan Drugs (2015-2026)
9.4 Global Forecasted Production of Orphan Drugs by Region (2021-2026)
9.4.1 North America Orphan Drugs Production, Revenue Forecast (2021-2026)
9.4.2 East Asia Orphan Drugs Production, Revenue Forecast (2021-2026)
9.4.3 Europe Orphan Drugs Production, Revenue Forecast (2021-2026)
9.4.4 South Asia Orphan Drugs Production, Revenue Forecast (2021-2026)
9.4.5 Southeast Asia Orphan Drugs Production, Revenue Forecast (2021-2026)
9.4.6 Middle East Orphan Drugs Production, Revenue Forecast (2021-2026)
9.4.7 Africa Orphan Drugs Production, Revenue Forecast (2021-2026)
9.4.8 Oceania Orphan Drugs Production, Revenue Forecast (2021-2026)
9.4.9 South America Orphan Drugs Production, Revenue Forecast (2021-2026)
9.4.10 Rest of the World Orphan Drugs Production, Revenue Forecast (2021-2026)
9.5 Forecast by Type and by Application (2021-2026)
9.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
9.5.2 Global Forecasted Consumption of Orphan Drugs by Application (2021-2026)
10 CONSUMPTION AND DEMAND FORECAST
10.1 North America Forecasted Consumption of Orphan Drugs by Country
10.2 East Asia Market Forecasted Consumption of Orphan Drugs by Country
10.3 Europe Market Forecasted Consumption of Orphan Drugs by Countriy
10.4 South Asia Forecasted Consumption of Orphan Drugs by Country
10.5 Southeast Asia Forecasted Consumption of Orphan Drugs by Country
10.6 Middle East Forecasted Consumption of Orphan Drugs by Country
10.7 Africa Forecasted Consumption of Orphan Drugs by Country
10.8 Oceania Forecasted Consumption of Orphan Drugs by Country
10.9 South America Forecasted Consumption of Orphan Drugs by Country
10.10 Rest of the world Forecasted Consumption of Orphan Drugs by Country
11 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
11.1 Marketing Channel
11.2 Orphan Drugs Distributors List
11.3 Orphan Drugs Customers
12 INDUSTRY TRENDS AND GROWTH STRATEGY
12.1 Market Top Trends
12.2 Market Drivers
12.3 Market Challenges
12.4 Porter’s Five Forces Analysis
12.5 Orphan Drugs Market Growth Strategy
13 ANALYST'S VIEWPOINTS/CONCLUSIONS
14 APPENDIX
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Disclaimer
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Orphan Drugs Revenue
1.4 Market Analysis by Type
1.4.1 Global Orphan Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Oncology
1.4.3 Gastrointestinal
1.4.4 Pulmonary
1.4.5 Neurology
1.4.6 Hematology
1.4.7 Cardio-vascular
1.4.8 Metabolic disorders
1.4.9 Endocrinology
1.4.10 Infectious diseases
1.5 Market by Application
1.5.1 Global Orphan Drugs Market Share by Application: 2021-2026
1.5.2 Hospital Pharmacies
1.5.3 Speciality Pharmacies
1.5.4 Retail pharmacies
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Orphan Drugs Market Perspective (2021-2026)
2.2 Orphan Drugs Growth Trends by Regions
2.2.1 Orphan Drugs Market Size by Regions: 2015 VS 2021 VS 2026
2.2.2 Orphan Drugs Historic Market Size by Regions (2015-2020)
2.2.3 Orphan Drugs Forecasted Market Size by Regions (2021-2026)
3 MARKET COMPETITION BY MANUFACTURERS
3.1 Global Orphan Drugs Production Capacity Market Share by Manufacturers (2015-2020)
3.2 Global Orphan Drugs Revenue Market Share by Manufacturers (2015-2020)
3.3 Global Orphan Drugs Average Price by Manufacturers (2015-2020)
4 ORPHAN DRUGS PRODUCTION BY REGIONS
4.1 North America
4.1.1 North America Orphan Drugs Market Size (2015-2026)
4.1.2 Orphan Drugs Key Players in North America (2015-2020)
4.1.3 North America Orphan Drugs Market Size by Type (2015-2020)
4.1.4 North America Orphan Drugs Market Size by Application (2015-2020)
4.2 East Asia
4.2.1 East Asia Orphan Drugs Market Size (2015-2026)
4.2.2 Orphan Drugs Key Players in East Asia (2015-2020)
4.2.3 East Asia Orphan Drugs Market Size by Type (2015-2020)
4.2.4 East Asia Orphan Drugs Market Size by Application (2015-2020)
4.3 Europe
4.3.1 Europe Orphan Drugs Market Size (2015-2026)
4.3.2 Orphan Drugs Key Players in Europe (2015-2020)
4.3.3 Europe Orphan Drugs Market Size by Type (2015-2020)
4.3.4 Europe Orphan Drugs Market Size by Application (2015-2020)
4.4 South Asia
4.4.1 South Asia Orphan Drugs Market Size (2015-2026)
4.4.2 Orphan Drugs Key Players in South Asia (2015-2020)
4.4.3 South Asia Orphan Drugs Market Size by Type (2015-2020)
4.4.4 South Asia Orphan Drugs Market Size by Application (2015-2020)
4.5 Southeast Asia
4.5.1 Southeast Asia Orphan Drugs Market Size (2015-2026)
4.5.2 Orphan Drugs Key Players in Southeast Asia (2015-2020)
4.5.3 Southeast Asia Orphan Drugs Market Size by Type (2015-2020)
4.5.4 Southeast Asia Orphan Drugs Market Size by Application (2015-2020)
4.6 Middle East
4.6.1 Middle East Orphan Drugs Market Size (2015-2026)
4.6.2 Orphan Drugs Key Players in Middle East (2015-2020)
4.6.3 Middle East Orphan Drugs Market Size by Type (2015-2020)
4.6.4 Middle East Orphan Drugs Market Size by Application (2015-2020)
4.7 Africa
4.7.1 Africa Orphan Drugs Market Size (2015-2026)
4.7.2 Orphan Drugs Key Players in Africa (2015-2020)
4.7.3 Africa Orphan Drugs Market Size by Type (2015-2020)
4.7.4 Africa Orphan Drugs Market Size by Application (2015-2020)
4.8 Oceania
4.8.1 Oceania Orphan Drugs Market Size (2015-2026)
4.8.2 Orphan Drugs Key Players in Oceania (2015-2020)
4.8.3 Oceania Orphan Drugs Market Size by Type (2015-2020)
4.8.4 Oceania Orphan Drugs Market Size by Application (2015-2020)
4.9 South America
4.9.1 South America Orphan Drugs Market Size (2015-2026)
4.9.2 Orphan Drugs Key Players in South America (2015-2020)
4.9.3 South America Orphan Drugs Market Size by Type (2015-2020)
4.9.4 South America Orphan Drugs Market Size by Application (2015-2020)
4.10 Rest of the World
4.10.1 Rest of the World Orphan Drugs Market Size (2015-2026)
4.10.2 Orphan Drugs Key Players in Rest of the World (2015-2020)
4.10.3 Rest of the World Orphan Drugs Market Size by Type (2015-2020)
4.10.4 Rest of the World Orphan Drugs Market Size by Application (2015-2020)
5 ORPHAN DRUGS CONSUMPTION BY REGION
5.1 North America
5.1.1 North America Orphan Drugs Consumption by Countries
5.1.2 United States
5.1.3 Canada
5.1.4 Mexico
5.2 East Asia
5.2.1 East Asia Orphan Drugs Consumption by Countries
5.2.2 China
5.2.3 Japan
5.2.4 South Korea
5.3 Europe
5.3.1 Europe Orphan Drugs Consumption by Countries
5.3.2 Germany
5.3.3 United Kingdom
5.3.4 France
5.3.5 Italy
5.3.6 Russia
5.3.7 Spain
5.3.8 Netherlands
5.3.9 Switzerland
5.3.10 Poland
5.4 South Asia
5.4.1 South Asia Orphan Drugs Consumption by Countries
5.4.2 India
5.4.3 Pakistan
5.4.4 Bangladesh
5.5 Southeast Asia
5.5.1 Southeast Asia Orphan Drugs Consumption by Countries
5.5.2 Indonesia
5.5.3 Thailand
5.5.4 Singapore
5.5.5 Malaysia
5.5.6 Philippines
5.5.7 Vietnam
5.5.8 Myanmar
5.6 Middle East
5.6.1 Middle East Orphan Drugs Consumption by Countries
5.6.2 Turkey
5.6.3 Saudi Arabia
5.6.4 Iran
5.6.5 United Arab Emirates
5.6.6 Israel
5.6.7 Iraq
5.6.8 Qatar
5.6.9 Kuwait
5.6.10 Oman
5.7 Africa
5.7.1 Africa Orphan Drugs Consumption by Countries
5.7.2 Nigeria
5.7.3 South Africa
5.7.4 Egypt
5.7.5 Algeria
5.7.6 Morocco
5.8 Oceania
5.8.1 Oceania Orphan Drugs Consumption by Countries
5.8.2 Australia
5.8.3 New Zealand
5.9 South America
5.9.1 South America Orphan Drugs Consumption by Countries
5.9.2 Brazil
5.9.3 Argentina
5.9.4 Columbia
5.9.5 Chile
5.9.6 Venezuela
5.9.7 Peru
5.9.8 Puerto Rico
5.9.9 Ecuador
5.10 Rest of the World
5.10.1 Rest of the World Orphan Drugs Consumption by Countries
5.10.2 Kazakhstan
6 ORPHAN DRUGS SALES MARKET BY TYPE (2015-2026)
6.1 Global Orphan Drugs Historic Market Size by Type (2015-2020)
6.2 Global Orphan Drugs Forecasted Market Size by Type (2021-2026)
7 ORPHAN DRUGS CONSUMPTION MARKET BY APPLICATION(2015-2026)
7.1 Global Orphan Drugs Historic Market Size by Application (2015-2020)
7.2 Global Orphan Drugs Forecasted Market Size by Application (2021-2026)
8 COMPANY PROFILES AND KEY FIGURES IN ORPHAN DRUGS BUSINESS
8.1 Novartis AG
8.1.1 Novartis AG Company Profile
8.1.2 Novartis AG Orphan Drugs Product Specification
8.1.3 Novartis AG Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.2 Eli Lilly and Company
8.2.1 Eli Lilly and Company Company Profile
8.2.2 Eli Lilly and Company Orphan Drugs Product Specification
8.2.3 Eli Lilly and Company Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.3 F. Hoffmann-La Roche Ltd.
8.3.1 F. Hoffmann-La Roche Ltd. Company Profile
8.3.2 F. Hoffmann-La Roche Ltd. Orphan Drugs Product Specification
8.3.3 F. Hoffmann-La Roche Ltd. Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.4 Bristol-Myers Squibb Company
8.4.1 Bristol-Myers Squibb Company Company Profile
8.4.2 Bristol-Myers Squibb Company Orphan Drugs Product Specification
8.4.3 Bristol-Myers Squibb Company Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.5 Alexion Pharmaceuticals, Inc.
8.5.1 Alexion Pharmaceuticals, Inc. Company Profile
8.5.2 Alexion Pharmaceuticals, Inc. Orphan Drugs Product Specification
8.5.3 Alexion Pharmaceuticals, Inc. Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.6 Celgene Corporation
8.6.1 Celgene Corporation Company Profile
8.6.2 Celgene Corporation Orphan Drugs Product Specification
8.6.3 Celgene Corporation Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.7 AstraZeneca
8.7.1 AstraZeneca Company Profile
8.7.2 AstraZeneca Orphan Drugs Product Specification
8.7.3 AstraZeneca Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.8 Sanofi S.A.
8.8.1 Sanofi S.A. Company Profile
8.8.2 Sanofi S.A. Orphan Drugs Product Specification
8.8.3 Sanofi S.A. Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.9 Pfizer, Inc.
8.9.1 Pfizer, Inc. Company Profile
8.9.2 Pfizer, Inc. Orphan Drugs Product Specification
8.9.3 Pfizer, Inc. Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.10 Novo Nordisk A/S
8.10.1 Novo Nordisk A/S Company Profile
8.10.2 Novo Nordisk A/S Orphan Drugs Product Specification
8.10.3 Novo Nordisk A/S Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.11 Merck & Co., Inc.
8.11.1 Merck & Co., Inc. Company Profile
8.11.2 Merck & Co., Inc. Orphan Drugs Product Specification
8.11.3 Merck & Co., Inc. Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.12 Takeda
8.12.1 Takeda Company Profile
8.12.2 Takeda Orphan Drugs Product Specification
8.12.3 Takeda Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.13 Eisai Co., Ltd.
8.13.1 Eisai Co., Ltd. Company Profile
8.13.2 Eisai Co., Ltd. Orphan Drugs Product Specification
8.13.3 Eisai Co., Ltd. Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.14 Johnson & Johnson
8.14.1 Johnson & Johnson Company Profile
8.14.2 Johnson & Johnson Orphan Drugs Product Specification
8.14.3 Johnson & Johnson Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.15 GlaxoSmithKline
8.15.1 GlaxoSmithKline Company Profile
8.15.2 GlaxoSmithKline Orphan Drugs Product Specification
8.15.3 GlaxoSmithKline Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.16 Daiichi Sankyo Company Limited
8.16.1 Daiichi Sankyo Company Limited Company Profile
8.16.2 Daiichi Sankyo Company Limited Orphan Drugs Product Specification
8.16.3 Daiichi Sankyo Company Limited Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.17 Amgen, Inc.
8.17.1 Amgen, Inc. Company Profile
8.17.2 Amgen, Inc. Orphan Drugs Product Specification
8.17.3 Amgen, Inc. Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.18 Biogen, Inc.
8.18.1 Biogen, Inc. Company Profile
8.18.2 Biogen, Inc. Orphan Drugs Product Specification
8.18.3 Biogen, Inc. Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.19 Bayer AG
8.19.1 Bayer AG Company Profile
8.19.2 Bayer AG Orphan Drugs Product Specification
8.19.3 Bayer AG Orphan Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
9 PRODUCTION AND SUPPLY FORECAST
9.1 Global Forecasted Production of Orphan Drugs (2021-2026)
9.2 Global Forecasted Revenue of Orphan Drugs (2021-2026)
9.3 Global Forecasted Price of Orphan Drugs (2015-2026)
9.4 Global Forecasted Production of Orphan Drugs by Region (2021-2026)
9.4.1 North America Orphan Drugs Production, Revenue Forecast (2021-2026)
9.4.2 East Asia Orphan Drugs Production, Revenue Forecast (2021-2026)
9.4.3 Europe Orphan Drugs Production, Revenue Forecast (2021-2026)
9.4.4 South Asia Orphan Drugs Production, Revenue Forecast (2021-2026)
9.4.5 Southeast Asia Orphan Drugs Production, Revenue Forecast (2021-2026)
9.4.6 Middle East Orphan Drugs Production, Revenue Forecast (2021-2026)
9.4.7 Africa Orphan Drugs Production, Revenue Forecast (2021-2026)
9.4.8 Oceania Orphan Drugs Production, Revenue Forecast (2021-2026)
9.4.9 South America Orphan Drugs Production, Revenue Forecast (2021-2026)
9.4.10 Rest of the World Orphan Drugs Production, Revenue Forecast (2021-2026)
9.5 Forecast by Type and by Application (2021-2026)
9.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
9.5.2 Global Forecasted Consumption of Orphan Drugs by Application (2021-2026)
10 CONSUMPTION AND DEMAND FORECAST
10.1 North America Forecasted Consumption of Orphan Drugs by Country
10.2 East Asia Market Forecasted Consumption of Orphan Drugs by Country
10.3 Europe Market Forecasted Consumption of Orphan Drugs by Countriy
10.4 South Asia Forecasted Consumption of Orphan Drugs by Country
10.5 Southeast Asia Forecasted Consumption of Orphan Drugs by Country
10.6 Middle East Forecasted Consumption of Orphan Drugs by Country
10.7 Africa Forecasted Consumption of Orphan Drugs by Country
10.8 Oceania Forecasted Consumption of Orphan Drugs by Country
10.9 South America Forecasted Consumption of Orphan Drugs by Country
10.10 Rest of the world Forecasted Consumption of Orphan Drugs by Country
11 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
11.1 Marketing Channel
11.2 Orphan Drugs Distributors List
11.3 Orphan Drugs Customers
12 INDUSTRY TRENDS AND GROWTH STRATEGY
12.1 Market Top Trends
12.2 Market Drivers
12.3 Market Challenges
12.4 Porter’s Five Forces Analysis
12.5 Orphan Drugs Market Growth Strategy
13 ANALYST'S VIEWPOINTS/CONCLUSIONS
14 APPENDIX
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Disclaimer
LIST OF TABLES AND FIGURES
Table 1. Global Orphan Drugs Market Share by Type: 2020 VS 2026
Table 2. Oncology Features
Table 3. Gastrointestinal Features
Table 4. Pulmonary Features
Table 5. Neurology Features
Table 6. Hematology Features
Table 7. Cardio-vascular Features
Table 8. Metabolic disorders Features
Table 9. Endocrinology Features
Table 10. Infectious diseases Features
Table 11. Global Orphan Drugs Market Share by Application: 2020 VS 2026
Table 12. Hospital Pharmacies Case Studies
Table 13. Speciality Pharmacies Case Studies
Table 14. Retail pharmacies Case Studies
Table 15. Others Case Studies
Table 21. Commodity Prices-Metals Price Indices
Table 22. Commodity Prices- Precious Metal Price Indices
Table 23. Commodity Prices- Agricultural Raw Material Price Indices
Table 24. Commodity Prices- Food and Beverage Price Indices
Table 25. Commodity Prices- Fertilizer Price Indices
Table 26. Commodity Prices- Energy Price Indices
Table 27. G20+: Economic Policy Responses to COVID-19
Table 28. Orphan Drugs Report Years Considered
Table 29. Global Orphan Drugs Market Size YoY Growth 2021-2026 (US$ Million)
Table 30. Global Orphan Drugs Market Share by Regions: 2021 VS 2026
Table 31. North America Orphan Drugs Market Size YoY Growth (2015-2026) (US$ Million)
Table 32. East Asia Orphan Drugs Market Size YoY Growth (2015-2026) (US$ Million)
Table 33. Europe Orphan Drugs Market Size YoY Growth (2015-2026) (US$ Million)
Table 34. South Asia Orphan Drugs Market Size YoY Growth (2015-2026) (US$ Million)
Table 35. Southeast Asia Orphan Drugs Market Size YoY Growth (2015-2026) (US$ Million)
Table 36. Middle East Orphan Drugs Market Size YoY Growth (2015-2026) (US$ Million)
Table 37. Africa Orphan Drugs Market Size YoY Growth (2015-2026) (US$ Million)
Table 38. Oceania Orphan Drugs Market Size YoY Growth (2015-2026) (US$ Million)
Table 39. South America Orphan Drugs Market Size YoY Growth (2015-2026) (US$ Million)
Table 40. Rest of the World Orphan Drugs Market Size YoY Growth (2015-2026) (US$ Million)
Table 41. North America Orphan Drugs Consumption by Countries (2015-2020)
Table 42. East Asia Orphan Drugs Consumption by Countries (2015-2020)
Table 43. Europe Orphan Drugs Consumption by Region (2015-2020)
Table 44. South Asia Orphan Drugs Consumption by Countries (2015-2020)
Table 45. Southeast Asia Orphan Drugs Consumption by Countries (2015-2020)
Table 46. Middle East Orphan Drugs Consumption by Countries (2015-2020)
Table 47. Africa Orphan Drugs Consumption by Countries (2015-2020)
Table 48. Oceania Orphan Drugs Consumption by Countries (2015-2020)
Table 49. South America Orphan Drugs Consumption by Countries (2015-2020)
Table 50. Rest of the World Orphan Drugs Consumption by Countries (2015-2020)
Table 51. Novartis AG Orphan Drugs Product Specification
Table 52. Eli Lilly and Company Orphan Drugs Product Specification
Table 53. F. Hoffmann-La Roche Ltd. Orphan Drugs Product Specification
Table 54. Bristol-Myers Squibb Company Orphan Drugs Product Specification
Table 55. Alexion Pharmaceuticals, Inc. Orphan Drugs Product Specification
Table 56. Celgene Corporation Orphan Drugs Product Specification
Table 57. AstraZeneca Orphan Drugs Product Specification
Table 58. Sanofi S.A. Orphan Drugs Product Specification
Table 59. Pfizer, Inc. Orphan Drugs Product Specification
Table 60. Novo Nordisk A/S Orphan Drugs Product Specification
Table 61. Merck & Co., Inc. Orphan Drugs Product Specification
Table 62. Takeda Orphan Drugs Product Specification
Table 63. Eisai Co., Ltd. Orphan Drugs Product Specification
Table 64. Johnson & Johnson Orphan Drugs Product Specification
Table 65. GlaxoSmithKline Orphan Drugs Product Specification
Table 66. Daiichi Sankyo Company Limited Orphan Drugs Product Specification
Table 67. Amgen, Inc. Orphan Drugs Product Specification
Table 68. Biogen, Inc. Orphan Drugs Product Specification
Table 69. Bayer AG Orphan Drugs Product Specification
Table 101. Global Orphan Drugs Production Forecast by Region (2021-2026)
Table 102. Global Orphan Drugs Sales Volume Forecast by Type (2021-2026)
Table 103. Global Orphan Drugs Sales Volume Market Share Forecast by Type (2021-2026)
Table 104. Global Orphan Drugs Sales Revenue Forecast by Type (2021-2026)
Table 105. Global Orphan Drugs Sales Revenue Market Share Forecast by Type (2021-2026)
Table 106. Global Orphan Drugs Sales Price Forecast by Type (2021-2026)
Table 107. Global Orphan Drugs Consumption Volume Forecast by Application (2021-2026)
Table 108. Global Orphan Drugs Consumption Value Forecast by Application (2021-2026)
Table 109. North America Orphan Drugs Consumption Forecast 2021-2026 by Country
Table 110. East Asia Orphan Drugs Consumption Forecast 2021-2026 by Country
Table 111. Europe Orphan Drugs Consumption Forecast 2021-2026 by Country
Table 112. South Asia Orphan Drugs Consumption Forecast 2021-2026 by Country
Table 113. Southeast Asia Orphan Drugs Consumption Forecast 2021-2026 by Country
Table 114. Middle East Orphan Drugs Consumption Forecast 2021-2026 by Country
Table 115. Africa Orphan Drugs Consumption Forecast 2021-2026 by Country
Table 116. Oceania Orphan Drugs Consumption Forecast 2021-2026 by Country
Table 117. South America Orphan Drugs Consumption Forecast 2021-2026 by Country
Table 118. Rest of the world Orphan Drugs Consumption Forecast 2021-2026 by Country
Table 119. Orphan Drugs Distributors List
Table 120. Orphan Drugs Customers List
Table 121. Porter's Five Forces Analysis
Table 122. Key Executives Interviewed
Figure 1. North America Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 2. North America Orphan Drugs Consumption Market Share by Countries in 2020
Figure 3. United States Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 4. Canada Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 5. Mexico Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 6. East Asia Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 7. East Asia Orphan Drugs Consumption Market Share by Countries in 2020
Figure 8. China Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 9. Japan Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 10. South Korea Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 11. Europe Orphan Drugs Consumption and Growth Rate
Figure 12. Europe Orphan Drugs Consumption Market Share by Region in 2020
Figure 13. Germany Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 14. United Kingdom Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 15. France Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 16. Italy Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 17. Russia Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 18. Spain Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 19. Netherlands Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 20. Switzerland Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 21. Poland Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 22. South Asia Orphan Drugs Consumption and Growth Rate
Figure 23. South Asia Orphan Drugs Consumption Market Share by Countries in 2020
Figure 24. India Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 25. Pakistan Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 26. Bangladesh Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 27. Southeast Asia Orphan Drugs Consumption and Growth Rate
Figure 28. Southeast Asia Orphan Drugs Consumption Market Share by Countries in 2020
Figure 29. Indonesia Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 30. Thailand Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 31. Singapore Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 32. Malaysia Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 33. Philippines Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 34. Vietnam Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 35. Myanmar Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 36. Middle East Orphan Drugs Consumption and Growth Rate
Figure 37. Middle East Orphan Drugs Consumption Market Share by Countries in 2020
Figure 38. Turkey Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 39. Saudi Arabia Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 40. Iran Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 41. United Arab Emirates Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 42. Israel Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 43. Iraq Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 44. Qatar Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 45. Kuwait Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 46. Oman Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 47. Africa Orphan Drugs Consumption and Growth Rate
Figure 48. Africa Orphan Drugs Consumption Market Share by Countries in 2020
Figure 49. Nigeria Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 50. South Africa Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 51. Egypt Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 52. Algeria Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 53. Morocco Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 54. Oceania Orphan Drugs Consumption and Growth Rate
Figure 55. Oceania Orphan Drugs Consumption Market Share by Countries in 2020
Figure 56. Australia Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 57. New Zealand Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 58. South America Orphan Drugs Consumption and Growth Rate
Figure 59. South America Orphan Drugs Consumption Market Share by Countries in 2020
Figure 60. Brazil Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 61. Argentina Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 62. Columbia Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 63. Chile Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 64. Venezuelal Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 65. Peru Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 66. Puerto Rico Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 67. Ecuador Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 68. Rest of the World Orphan Drugs Consumption and Growth Rate
Figure 69. Rest of the World Orphan Drugs Consumption Market Share by Countries in 2020
Figure 70. Kazakhstan Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 71. Global Orphan Drugs Production Capacity Growth Rate Forecast (2021-2026)
Figure 72. Global Orphan Drugs Revenue Growth Rate Forecast (2021-2026)
Figure 73. Global Orphan Drugs Price and Trend Forecast (2015-2026)
Figure 74. North America Orphan Drugs Production Growth Rate Forecast (2021-2026)
Figure 75. North America Orphan Drugs Revenue Growth Rate Forecast (2021-2026)
Figure 76. East Asia Orphan Drugs Production Growth Rate Forecast (2021-2026)
Figure 77. East Asia Orphan Drugs Revenue Growth Rate Forecast (2021-2026)
Figure 78. Europe Orphan Drugs Production Growth Rate Forecast (2021-2026)
Figure 79. Europe Orphan Drugs Revenue Growth Rate Forecast (2021-2026)
Figure 80. South Asia Orphan Drugs Production Growth Rate Forecast (2021-2026)
Figure 81. South Asia Orphan Drugs Revenue Growth Rate Forecast (2021-2026)
Figure 82. Southeast Asia Orphan Drugs Production Growth Rate Forecast (2021-2026)
Figure 83. Southeast Asia Orphan Drugs Revenue Growth Rate Forecast (2021-2026)
Figure 84. Middle East Orphan Drugs Production Growth Rate Forecast (2021-2026)
Figure 85. Middle East Orphan Drugs Revenue Growth Rate Forecast (2021-2026)
Figure 86. Africa Orphan Drugs Production Growth Rate Forecast (2021-2026)
Figure 87. Africa Orphan Drugs Revenue Growth Rate Forecast (2021-2026)
Figure 88. Oceania Orphan Drugs Production Growth Rate Forecast (2021-2026)
Figure 89. Oceania Orphan Drugs Revenue Growth Rate Forecast (2021-2026)
Figure 90. South America Orphan Drugs Production Growth Rate Forecast (2021-2026)
Figure 91. South America Orphan Drugs Revenue Growth Rate Forecast (2021-2026)
Figure 92. Rest of the World Orphan Drugs Production Growth Rate Forecast (2021-2026)
Figure 93. Rest of the World Orphan Drugs Revenue Growth Rate Forecast (2021-2026)
Figure 94. North America Orphan Drugs Consumption Forecast 2021-2026
Figure 95. East Asia Orphan Drugs Consumption Forecast 2021-2026
Figure 96. Europe Orphan Drugs Consumption Forecast 2021-2026
Figure 97. South Asia Orphan Drugs Consumption Forecast 2021-2026
Figure 98. Southeast Asia Orphan Drugs Consumption Forecast 2021-2026
Figure 99. Middle East Orphan Drugs Consumption Forecast 2021-2026
Figure 100. Africa Orphan Drugs Consumption Forecast 2021-2026
Figure 101. Oceania Orphan Drugs Consumption Forecast 2021-2026
Figure 102. South America Orphan Drugs Consumption Forecast 2021-2026
Figure 103. Rest of the world Orphan Drugs Consumption Forecast 2021-2026
Figure 104. Channels of Distribution
Figure 105. Distributors Profiles
Table 1. Global Orphan Drugs Market Share by Type: 2020 VS 2026
Table 2. Oncology Features
Table 3. Gastrointestinal Features
Table 4. Pulmonary Features
Table 5. Neurology Features
Table 6. Hematology Features
Table 7. Cardio-vascular Features
Table 8. Metabolic disorders Features
Table 9. Endocrinology Features
Table 10. Infectious diseases Features
Table 11. Global Orphan Drugs Market Share by Application: 2020 VS 2026
Table 12. Hospital Pharmacies Case Studies
Table 13. Speciality Pharmacies Case Studies
Table 14. Retail pharmacies Case Studies
Table 15. Others Case Studies
Table 21. Commodity Prices-Metals Price Indices
Table 22. Commodity Prices- Precious Metal Price Indices
Table 23. Commodity Prices- Agricultural Raw Material Price Indices
Table 24. Commodity Prices- Food and Beverage Price Indices
Table 25. Commodity Prices- Fertilizer Price Indices
Table 26. Commodity Prices- Energy Price Indices
Table 27. G20+: Economic Policy Responses to COVID-19
Table 28. Orphan Drugs Report Years Considered
Table 29. Global Orphan Drugs Market Size YoY Growth 2021-2026 (US$ Million)
Table 30. Global Orphan Drugs Market Share by Regions: 2021 VS 2026
Table 31. North America Orphan Drugs Market Size YoY Growth (2015-2026) (US$ Million)
Table 32. East Asia Orphan Drugs Market Size YoY Growth (2015-2026) (US$ Million)
Table 33. Europe Orphan Drugs Market Size YoY Growth (2015-2026) (US$ Million)
Table 34. South Asia Orphan Drugs Market Size YoY Growth (2015-2026) (US$ Million)
Table 35. Southeast Asia Orphan Drugs Market Size YoY Growth (2015-2026) (US$ Million)
Table 36. Middle East Orphan Drugs Market Size YoY Growth (2015-2026) (US$ Million)
Table 37. Africa Orphan Drugs Market Size YoY Growth (2015-2026) (US$ Million)
Table 38. Oceania Orphan Drugs Market Size YoY Growth (2015-2026) (US$ Million)
Table 39. South America Orphan Drugs Market Size YoY Growth (2015-2026) (US$ Million)
Table 40. Rest of the World Orphan Drugs Market Size YoY Growth (2015-2026) (US$ Million)
Table 41. North America Orphan Drugs Consumption by Countries (2015-2020)
Table 42. East Asia Orphan Drugs Consumption by Countries (2015-2020)
Table 43. Europe Orphan Drugs Consumption by Region (2015-2020)
Table 44. South Asia Orphan Drugs Consumption by Countries (2015-2020)
Table 45. Southeast Asia Orphan Drugs Consumption by Countries (2015-2020)
Table 46. Middle East Orphan Drugs Consumption by Countries (2015-2020)
Table 47. Africa Orphan Drugs Consumption by Countries (2015-2020)
Table 48. Oceania Orphan Drugs Consumption by Countries (2015-2020)
Table 49. South America Orphan Drugs Consumption by Countries (2015-2020)
Table 50. Rest of the World Orphan Drugs Consumption by Countries (2015-2020)
Table 51. Novartis AG Orphan Drugs Product Specification
Table 52. Eli Lilly and Company Orphan Drugs Product Specification
Table 53. F. Hoffmann-La Roche Ltd. Orphan Drugs Product Specification
Table 54. Bristol-Myers Squibb Company Orphan Drugs Product Specification
Table 55. Alexion Pharmaceuticals, Inc. Orphan Drugs Product Specification
Table 56. Celgene Corporation Orphan Drugs Product Specification
Table 57. AstraZeneca Orphan Drugs Product Specification
Table 58. Sanofi S.A. Orphan Drugs Product Specification
Table 59. Pfizer, Inc. Orphan Drugs Product Specification
Table 60. Novo Nordisk A/S Orphan Drugs Product Specification
Table 61. Merck & Co., Inc. Orphan Drugs Product Specification
Table 62. Takeda Orphan Drugs Product Specification
Table 63. Eisai Co., Ltd. Orphan Drugs Product Specification
Table 64. Johnson & Johnson Orphan Drugs Product Specification
Table 65. GlaxoSmithKline Orphan Drugs Product Specification
Table 66. Daiichi Sankyo Company Limited Orphan Drugs Product Specification
Table 67. Amgen, Inc. Orphan Drugs Product Specification
Table 68. Biogen, Inc. Orphan Drugs Product Specification
Table 69. Bayer AG Orphan Drugs Product Specification
Table 101. Global Orphan Drugs Production Forecast by Region (2021-2026)
Table 102. Global Orphan Drugs Sales Volume Forecast by Type (2021-2026)
Table 103. Global Orphan Drugs Sales Volume Market Share Forecast by Type (2021-2026)
Table 104. Global Orphan Drugs Sales Revenue Forecast by Type (2021-2026)
Table 105. Global Orphan Drugs Sales Revenue Market Share Forecast by Type (2021-2026)
Table 106. Global Orphan Drugs Sales Price Forecast by Type (2021-2026)
Table 107. Global Orphan Drugs Consumption Volume Forecast by Application (2021-2026)
Table 108. Global Orphan Drugs Consumption Value Forecast by Application (2021-2026)
Table 109. North America Orphan Drugs Consumption Forecast 2021-2026 by Country
Table 110. East Asia Orphan Drugs Consumption Forecast 2021-2026 by Country
Table 111. Europe Orphan Drugs Consumption Forecast 2021-2026 by Country
Table 112. South Asia Orphan Drugs Consumption Forecast 2021-2026 by Country
Table 113. Southeast Asia Orphan Drugs Consumption Forecast 2021-2026 by Country
Table 114. Middle East Orphan Drugs Consumption Forecast 2021-2026 by Country
Table 115. Africa Orphan Drugs Consumption Forecast 2021-2026 by Country
Table 116. Oceania Orphan Drugs Consumption Forecast 2021-2026 by Country
Table 117. South America Orphan Drugs Consumption Forecast 2021-2026 by Country
Table 118. Rest of the world Orphan Drugs Consumption Forecast 2021-2026 by Country
Table 119. Orphan Drugs Distributors List
Table 120. Orphan Drugs Customers List
Table 121. Porter's Five Forces Analysis
Table 122. Key Executives Interviewed
Figure 1. North America Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 2. North America Orphan Drugs Consumption Market Share by Countries in 2020
Figure 3. United States Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 4. Canada Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 5. Mexico Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 6. East Asia Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 7. East Asia Orphan Drugs Consumption Market Share by Countries in 2020
Figure 8. China Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 9. Japan Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 10. South Korea Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 11. Europe Orphan Drugs Consumption and Growth Rate
Figure 12. Europe Orphan Drugs Consumption Market Share by Region in 2020
Figure 13. Germany Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 14. United Kingdom Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 15. France Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 16. Italy Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 17. Russia Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 18. Spain Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 19. Netherlands Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 20. Switzerland Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 21. Poland Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 22. South Asia Orphan Drugs Consumption and Growth Rate
Figure 23. South Asia Orphan Drugs Consumption Market Share by Countries in 2020
Figure 24. India Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 25. Pakistan Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 26. Bangladesh Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 27. Southeast Asia Orphan Drugs Consumption and Growth Rate
Figure 28. Southeast Asia Orphan Drugs Consumption Market Share by Countries in 2020
Figure 29. Indonesia Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 30. Thailand Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 31. Singapore Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 32. Malaysia Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 33. Philippines Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 34. Vietnam Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 35. Myanmar Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 36. Middle East Orphan Drugs Consumption and Growth Rate
Figure 37. Middle East Orphan Drugs Consumption Market Share by Countries in 2020
Figure 38. Turkey Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 39. Saudi Arabia Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 40. Iran Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 41. United Arab Emirates Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 42. Israel Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 43. Iraq Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 44. Qatar Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 45. Kuwait Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 46. Oman Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 47. Africa Orphan Drugs Consumption and Growth Rate
Figure 48. Africa Orphan Drugs Consumption Market Share by Countries in 2020
Figure 49. Nigeria Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 50. South Africa Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 51. Egypt Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 52. Algeria Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 53. Morocco Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 54. Oceania Orphan Drugs Consumption and Growth Rate
Figure 55. Oceania Orphan Drugs Consumption Market Share by Countries in 2020
Figure 56. Australia Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 57. New Zealand Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 58. South America Orphan Drugs Consumption and Growth Rate
Figure 59. South America Orphan Drugs Consumption Market Share by Countries in 2020
Figure 60. Brazil Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 61. Argentina Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 62. Columbia Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 63. Chile Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 64. Venezuelal Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 65. Peru Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 66. Puerto Rico Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 67. Ecuador Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 68. Rest of the World Orphan Drugs Consumption and Growth Rate
Figure 69. Rest of the World Orphan Drugs Consumption Market Share by Countries in 2020
Figure 70. Kazakhstan Orphan Drugs Consumption and Growth Rate (2015-2020)
Figure 71. Global Orphan Drugs Production Capacity Growth Rate Forecast (2021-2026)
Figure 72. Global Orphan Drugs Revenue Growth Rate Forecast (2021-2026)
Figure 73. Global Orphan Drugs Price and Trend Forecast (2015-2026)
Figure 74. North America Orphan Drugs Production Growth Rate Forecast (2021-2026)
Figure 75. North America Orphan Drugs Revenue Growth Rate Forecast (2021-2026)
Figure 76. East Asia Orphan Drugs Production Growth Rate Forecast (2021-2026)
Figure 77. East Asia Orphan Drugs Revenue Growth Rate Forecast (2021-2026)
Figure 78. Europe Orphan Drugs Production Growth Rate Forecast (2021-2026)
Figure 79. Europe Orphan Drugs Revenue Growth Rate Forecast (2021-2026)
Figure 80. South Asia Orphan Drugs Production Growth Rate Forecast (2021-2026)
Figure 81. South Asia Orphan Drugs Revenue Growth Rate Forecast (2021-2026)
Figure 82. Southeast Asia Orphan Drugs Production Growth Rate Forecast (2021-2026)
Figure 83. Southeast Asia Orphan Drugs Revenue Growth Rate Forecast (2021-2026)
Figure 84. Middle East Orphan Drugs Production Growth Rate Forecast (2021-2026)
Figure 85. Middle East Orphan Drugs Revenue Growth Rate Forecast (2021-2026)
Figure 86. Africa Orphan Drugs Production Growth Rate Forecast (2021-2026)
Figure 87. Africa Orphan Drugs Revenue Growth Rate Forecast (2021-2026)
Figure 88. Oceania Orphan Drugs Production Growth Rate Forecast (2021-2026)
Figure 89. Oceania Orphan Drugs Revenue Growth Rate Forecast (2021-2026)
Figure 90. South America Orphan Drugs Production Growth Rate Forecast (2021-2026)
Figure 91. South America Orphan Drugs Revenue Growth Rate Forecast (2021-2026)
Figure 92. Rest of the World Orphan Drugs Production Growth Rate Forecast (2021-2026)
Figure 93. Rest of the World Orphan Drugs Revenue Growth Rate Forecast (2021-2026)
Figure 94. North America Orphan Drugs Consumption Forecast 2021-2026
Figure 95. East Asia Orphan Drugs Consumption Forecast 2021-2026
Figure 96. Europe Orphan Drugs Consumption Forecast 2021-2026
Figure 97. South Asia Orphan Drugs Consumption Forecast 2021-2026
Figure 98. Southeast Asia Orphan Drugs Consumption Forecast 2021-2026
Figure 99. Middle East Orphan Drugs Consumption Forecast 2021-2026
Figure 100. Africa Orphan Drugs Consumption Forecast 2021-2026
Figure 101. Oceania Orphan Drugs Consumption Forecast 2021-2026
Figure 102. South America Orphan Drugs Consumption Forecast 2021-2026
Figure 103. Rest of the world Orphan Drugs Consumption Forecast 2021-2026
Figure 104. Channels of Distribution
Figure 105. Distributors Profiles
